Institute of Biomedicine and Molecular Immunology, IBIM
Palermo, 90146, Italy
NCT Number: NCT02433275
"CHildhood ASthma and Environment Research study - CHASER study" is an observational longitudinal study in outpatient clinic of Pediatric Allergology & Pulmonology (PAP) of Respiratory Disease Research Center (RDRC) within the Institute of Biomedicine and Molecular Immunology (IBIM) of the National Research Council (CNR) of Palermo (RDRC-IBIM CNR), Italy.
The first phase - transversal study will identify determinants of pediatric asthma control
The second phase - longitudinal study, in patients with persistent asthma, will be focused on:
* predictors for asthma exacerbations and loss of control * real life adherence to asthma therapy guidelines * phenotypic characterization through the collection of saliva samples * assessment of alterations and inflammatory changes in the nasal mucosa through nasal brushing * evaluation of the presence of 8-isoprostane, nicotine, cotinine and bisphenol-A through urine analysis.
Chaser Project is expected to improve the knowledge of pediatric asthma in patients with different level of control, identifying predictors for asthma exacerbations and loss of control.
Looking for future studies?
Notify Me5 year–16 year
All sexes
Observational
Palermo, 90146, Italy
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 5 years
Time frame: 5 years
Time frame: 5 years
Time frame: 5 years
Stefania La Grutta, MD
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01721291
Asthma, Bronchial Diseases
London, United Kingdom
View Trial DetailsNCT05623059
Asthma, Bronchial Diseases
Indianapolis, Indiana, United States
View Trial DetailsNCT01399411
Asthma, Autoimmune Diseases
Iowa City, Illinois, United States
View Trial DetailsNCT01678222
Allergic Inflammation, Asthma
Research Triangle Park, North Carolina, United States
View Trial Details